Navigation Links
J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
Date:9/13/2007

WESTLAKE VILLAGE, Calif., Sept. 13 /PRNewswire/ -- Hackensack University Medical Center, a 781-bed teaching and research hospital located in Hackensack, N.J., and affiliated with The University of Medicine and Dentistry of New Jersey-New Jersey Medical School, is the first hospital to achieve distinction for providing an outstanding patient experience in all four service areas: inpatient, outpatient, emergency and maternity under the J.D. Power and Associates Distinguished Hospital Program(SM). In addition this marks the fourth consecutive year in which Hackensack University Medical Center has been recognized for service excellence.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050527/LAF028LOGO-a)

"Because patients place a high value on the service aspects of their hospital stay, providing them with a consistent, positive experience year after year is as important for hospitals as it is in any other service industry," said David Stefan, executive director of the healthcare division at J.D. Power and Associates.

The service excellence distinction was determined by surveying a random sample of recently discharged patients of Hackensack University Medical Center on their perceptions of their hospital stay. Patient feedback was then compared with the national benchmark established in the J.D. Power and Associates National Hospital Service Performance Study(SM).

The telephone-based research conducted among patients focuses on the five key drivers of patient satisfaction with their overall hospital experience: dignity and respect; speed and efficiency; comfort; information and communication; and emotional support.

Hackensack University Medical Center exceeded the national benchmark study score for overall inpatient, outpatient, emergency and maternity service satisfaction. In comparison to the national study, the hospital performed particularly well f
'/>"/>

SOURCE J.D. Power and Associates
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Antibiotics losing their power against acne
2. Chewing gum found to increase brainpower
3. New genital gel could empower women against the AIDS epidemic
4. Some languages require more brain power
5. Exercising To Music Found To Boost Brain Power
6. Stretching May Not Decrease Risk Of Injury In Power Sports
7. Zinc increases thinking power of children
8. Childhood leukemia linked to residence close to high voltage power lines
9. Warning Signs On Powered Baby Milk
10. Testing Your Health & Charging Your Mobile At One Go - Check Out The Urine Powered Batteries
11. Implantable devices to be powered by organosilicon compounds in the future

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Only 5 percent of seniors have changed Medicare...better service and improved coverage among biggest...eason nears , , Bellevill...cent of seniors have changed their Medicare plan s...rcent) report they are likely to or are considerin...
(Date:11/9/2009)...ifted young athletes are under increasing pressure...Loyola University Health System study of 519 junio...n increases the risk of injury. Researchers who an...iation junior competition found that players who s...draw from tournaments for medical reasons, typical...
(Date:11/8/2009)...8 Jon O,Brien, presiden...atement about the passage of HR 3962: ,, "Beha...ers a lot about core values. We in the prochoice c...o overcome the struggles ordinary Americans have m...nnot afford basic healthcare or have to choose bet...
(Date:11/8/2009)...t position promotes self-assurance, research finds...Your mother may have been right when she told you ...d posture could make you feel more confident about... sitting up straight gives a good impression to ot... and a psychology professor at Ohio State Universi...
(Date:11/8/2009)...8 Speaker Nancy Pelosi ...lowing the House passage of H.R. 3962, the Afforda...by a vote of 220 to 215. Below are the Speaker,s ...es just received a call from the President of the ...a great victory for the American people. I thank t...
Breaking Medicine News(10 mins):Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 2Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 3Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 4Health News:Few Change Medicare Plans Each Year, But Three Times as Many Are Considering a Change in 2010, Allsup Survey Finds, 5Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:Good Posture May Inspire Confidence 2
...e 47th Annual Meeting of the American Society for ...rado say that there is no direct link //between th...ess of prostate cancer, but the long-term survival...bsequent intensity of prostate cancer. Previous st...
...s the risk of colorectal tumours, while drinking w...study. // The study, conducted by Joseph C. A...sity, Stony Brook, New York, was meant to examine ...ients were subject to a survey of drinking habits ...
...from United Kingdom have found a new antibiotic ti...ation of Tetracycline known as Glycycline. // ... an increased incidence of antibiotic resistance s...tions in hospital. Staphylococcus aureus as shown ...
... interstitial fluid pressure (IFP) is negative, an... exposed, fluid does not seep out. //By contrast, ... barrier against efficient drug delivery into the ...itial space by convection (i.e. by streaming of a ...
...oor families who get fed in schools by the governm...ke up for their iron and vitamin deficiencies//. ...n pills, which have not found wide acceptance. Bes...a. The nutrition candy however should be seen as a...
...er is designated as the Breast Cancer Awareness Mo...hat despite the exponential morbidity and mortalit...d women are aware of what actually happens, what a...r Research Foundation, and Alexandra Penney, forme...
Other Medicine News:Health News:Alcohol Drinking Affects Risk Of Colorectal Tumours 2Health News:Tigecycline – New Generation Tetracycline With Broad Spectrum Antibacterial Activit 2Health News:A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues 2Health News:Vitamin filled nutrition candy for School children 2
(Date:11/6/2009)...SAN DIEGO, Nov. 6 NexBio Inc., in ...isease Control and Prevention (CDC), St. Louis Uni...d today the publication of two articles in the pee...studies suggest that DAS181 (Fludase ® ) may ...t and prevention of the Pandemic Influenza A(H1N1)...
(Date:11/6/2009)... PARIS, November 6 , -... Linezolid for the,Treatment of Multi-Resistant St...ovexel, a speciality pharmaceutical company focuse...otics designed to overcome the significant global,...hat its most advanced oral,antibacterial NXL103 (f...
(Date:11/5/2009)...POINT RICHMOND, Calif., Nov. 5 /PRNewswire-FirstCa...SPT ), a specialty pharmaceutical company focused ...etary products that address important therapeutic ...d it will host a webcast and teleconference with m...results on Thursday, November 12, 2009, at 5:00 p....
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 1Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 2Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 3Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 4Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 5Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 6Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 7Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer 57732 8Antigen Discovery Inc Awarded Grant for Chlamydia Vaccine Development 14163 1Antigen Discovery Inc Awarded Grant for Chlamydia Vaccine Development 14163 2Life Science Firms are Turning to Firmex to do Deals Online 14161 1Life Science Firms are Turning to Firmex to do Deals Online 14161 2Life Science Firms are Turning to Firmex to do Deals Online 14161 3
... PCOP ), an innovator in the discovery and develo...announced that Schering-Plough has,initiated a Pha...8115, a,compound identified from the collaboration...evaluated as a potential treatment for respiratory...ilestone payment from,Schering-Plough as a result ...
...Phase -, WALTHAM, Mass., Sept. 25 Arbios Systems...its clinical trial strategy for,the SEPET(TM) Live...pre-pivotal phase meeting with the US Food and Dru...Arbios and the FDA,s Office for Device Evaluation,...g receipt of a final,report, SEPET(TM) has met the...
Other Medicine Technology:Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 2Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 3Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate 4Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial 2Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial 3Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial 4
Human Cardiac-Specific Troponin-I Enzyme Immunoassay (cTnI ELISA)
Acute Care Cardiac Troponin I
... brings true automation and continuous random acce...y sensitive assays for thyroid, anemia, cardiac, r...bolism testing are currently available, with infec... ECi can simultaneously process 60 accessible samp...
Myoglobin Test Modules
Medicine Products: